27 Einträge gefunden

1. Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group

   1. Koschmieder, Steffen
   2. Isfort, Susanne
   3. Wolf, Dominik
   4. Heidel, Florian H
   5. Hochhaus, Andreas
   6. Schafhausen, Philippe
   7. Griesshammer, Martin

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia

   1. Janjetovic, Snjezana
   2. Rolling, Christina Charlotte
   3. Budde, Ulrich
   4. Schneppenhem, Sonja
   5. Schafhausen, Philippe
   6. Peters, Mia Carlotta
   7. Bokemeyer, Carsten

   2022 - Forschungsinformationssystem des UKE
3. Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)

   1. Hecht, Anna
   2. Meyer, Julia A
   3. Jann, Johann-Christoph
   4. Sockel, Katja
   5. Giagounidis, Aristoteles
   6. Götze, Katharina S
   7. Letsch, Anne

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation

   1. Janjetovic, Snjezana
   2. Beckmann, Lennart
   3. Holstein, Katharina
   4. Rolling, Christina
   5. Thiele, Benjamin
   6. Schafhausen, Philippe
   7. Schön, Gerhard

   2021 - Forschungsinformationssystem des UKE
5. AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms

   1. Beitzen-Heineke, Antonia
   2. Berenbrok, Nikolaus
   3. Waizenegger, Jonas Siddhartha
   4. Päsler, Sarina
   5. Gensch, Victoria
   6. Udonta, Florian
   7. Vargas-Delgado, Maria Elena

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma

   1. Zech, Henrike B
   2. Moeckelmann, Nikolaus
   3. Boettcher, Arne
   4. Muenscher, Adrian
   5. Binder, Mascha
   6. Vettorazzi, Eik
   7. Bokemeyer, Carsten

   2020 - Forschungsinformationssystem des UKE
7. Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg: Report of the University Cancer Center Hamburg

   1. Weisel, Katja C
   2. Morgner-Miehlke, Andrea
   3. Petersen, Cordula
   4. Fiedler, Walter
   5. Block, Andreas
   6. Schafhausen, Philippe
   7. Knobloch, Johannes K

   2020 - Forschungsinformationssystem des UKE
8. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib

   1. Janjetovic, Snjezana
   2. Asemissen, Anne Marie
   3. Dicker, Frank
   4. Binder, Mascha
   5. Dierlamm, Judith
   6. Bokemeyer, Carsten
   7. Schafhausen, Philippe

   2019 - Forschungsinformationssystem des UKE
9. Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR)

   1. Dimitriou, Vassiliki
   2. Biehl, Lena M
   3. Hamprecht, Axel
   4. Vogel, Wichard
   5. Dörfel, Daniela
   6. Peter, Silke
   7. Schafhausen, Philippe

   2019 - Forschungsinformationssystem des UKE
10. Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients

    1. Biehl, Lena M
    2. Garzetti, Debora
    3. Farowski, Fedja
    4. Ring, Diana
    5. Koeppel, Martin B
    6. Rohde, Holger
    7. Schafhausen, Philippe

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
11. Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study

    1. Gambacorti-Passerini, Carlo
    2. Cortes, Jorge E
    3. Lipton, Jeff H
    4. Kantarjian, Hagop M
    5. Kim, Dong-Wook
    6. Schafhausen, Philippe
    7. Crescenzo, Rocco

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
12. Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia

    1. Ben Batalla, Isabel
    2. Erdmann, Robert
    3. Jørgensen, Heather
    4. Mitchell, Rebecca
    5. Ernst, Thomas
    6. von Amsberg, Gunhild
    7. Schafhausen, Philippe

    2017 - Forschungsinformationssystem des UKE
13. Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

    1. Al-Ali, Haifa Kathrin
    2. Griesshammer, Martin
    3. le Coutre, Philipp
    4. Waller, Cornelius F
    5. Liberati, Anna Marina
    6. Schafhausen, Philippe
    7. Tavares, Renato

    2016 - Forschungsinformationssystem des UKE - frei zugänglich
14. Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib

    1. Brümmendorf, Tim H
    2. Cortes, Jorge E
    3. Khoury, Hanna J
    4. Kantarjian, Hagop M
    5. Kim, Dong-Wook
    6. Schafhausen, Philippe
    7. Conlan, Maureen G

    2016 - Forschungsinformationssystem des UKE
15. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature

    1. Zielinski, Valerie
    2. Laban, Simon
    3. Tribius, Silke
    4. Schafhausen, Philippe
    5. Veldhoen, Simon
    6. Knecht, Rainald
    7. Clauditz, Till

    2016 - Forschungsinformationssystem des UKE
16. Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib

    1. Cortes, Jorge E
    2. Khoury, Hanna J
    3. Kantarjian, Hagop M
    4. Lipton, Jeff H
    5. Kim, Dong-Wook
    6. Schafhausen, Philippe
    7. Matczak, Ewa

    2016 - Forschungsinformationssystem des UKE
17. Outcome and fewer indications for adjuvant therapy for patients with oral squamous cell carcinomas under standardized tumor board conditions

    1. Gröbe, Alexander
    2. Rybak, Lena
    3. Schön, Gerhard
    4. Smeets, Ralf
    5. Tribius, Silke
    6. Schafhausen, Philippe
    7. Clauditz, Till S

    2016 - Forschungsinformationssystem des UKE
18. A phase I study of Danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy

    1. Borthakur, Gautam
    2. Dombret, Herve
    3. Schafhausen, Philippe
    4. Brummendorf, Tim Henrik
    5. Boissel, Nicolas
    6. Jabbour, Elias
    7. Mariani, Mariangela

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
19. Bosutinib: a novel second-generation tyrosine kinase inhibitor

    1. Isfort, Susanne
    2. Amsberg, Gunhild
    3. Schafhausen, Philippe
    4. Koschmieder, Steffen
    5. Brümmendorf, Tim H

    2014 - Forschungsinformationssystem des UKE
20. Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity

    1. Harbaum, Lars
    2. Marx, Andreas
    3. Goekkurt, Eray
    4. Schafhausen, Philippe
    5. Atanackovic, Djordje

    2014 - Forschungsinformationssystem des UKE